Begs the question also - are the contract values disclosed/noted on the announcements capped? or just indicative at baseline sales being met then the value is i.e. $10m? In other words if they tripled expected sales of products would they bump past the $10m contract value? In other words uncapped? Think i brought this up before and some believed this was the case.
I should note that I had some old RLG Jan announcements, I think the Dec quarterly and investor presos etc. ANd noted a big chunk of the revenue at the times were service fees - store openings and all the initial items, but noted a marked increase % wise in product sales. Although it formed say an immaterial $700k of revenue for the quarter or YTD (forgot which). So a marked increase in product sales could, if complimented by ongoing service fee revenue from new clients, result in some exponential recurring revenue (assuming product sales are recurring/sticky).
I'd imagine /hope they're vetting not only trends but high quality companies that will have happy, repeat customers, at least if one wants to see recurring revenue.
- Forums
- ASX - By Stock
- RLG
- Unit Sales - update
Unit Sales - update, page-89
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RLG (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $3.911M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $8 | 1.957K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 14953614 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 3807551 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 14953614 | 0.004 |
6 | 3230264 | 0.003 |
7 | 5373670 | 0.002 |
6 | 8300000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 3807551 | 5 |
0.006 | 810000 | 3 |
0.007 | 140000 | 2 |
0.008 | 625160 | 3 |
0.010 | 194676 | 1 |
Last trade - 15.41pm 15/07/2024 (20 minute delay) ? |
Featured News
RLG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online